Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01805440 : Placebo-Controlled Study of Uridine for Adolescent Bipolar Depression
AgesMin: 13 Years Max: 21 Years
Inclusion Criteria:

- Participants 18 years of age and older must be able to grant consent and participants
under the age of 18 years must be abel to grant assent and parent/guardian

- Participants must be between the ages of 13 and 21 years.

- Participants must meet DSM-IV criteria for Bipolar Disorder (Type I, II, or NOS),
with current mood state depressed for at least 2 weeks.

- Participants must have current CDRS-R score of 45 or greater or MADRS score 25 or

Exclusion Criteria:

- Participants must not meet DSM-IV criteria for a psychotic or developmental disorder
or substance dependence.

- Participants must not currently be experiencing clinically significant suicidal or
homicidal risk.

- Participants must not be receiving treatment with an antipsychotic medication.

- Participants must not be pregnant or breastfeeding.

- Participants must not possess a contraindication to magnetic resonance imaging (e.g.,
ferromagnetic implant or claustrophobia).

- Participants may be outpatients or inpatients, but incarcerated persons will be
excluded because this study is not approved for "Research Involving Prisoners."
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557